BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26662433)

  • 1. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
    Lin N; Zhou Y; Lian X; Tu Y
    Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma.
    Jiang L; Lv X; Li J; Li J; Li X; Li W; Li Y
    Acta Histochem; 2012 Oct; 114(6):582-8. PubMed ID: 22130252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma.
    Lin N; Zhou Y; Lian X; Tu Y
    Int J Clin Exp Med; 2015; 8(3):4297-301. PubMed ID: 26064345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ hybridization analysis of the expression of miR-106b in colonic cancer.
    Wang YX; Lang F; Liu YX; Yang CQ; Gao HJ
    Int J Clin Exp Pathol; 2015; 8(1):786-92. PubMed ID: 25755775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
    Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
    Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients.
    Brunner G; Reitz M; Schwipper V; Tilkorn H; Lippold A; Biess B; Suter L; Atzpodien J
    Cancer Biother Radiopharm; 2008 Aug; 23(4):451-9. PubMed ID: 18771349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
    Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
    Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma.
    Li P; He QY; Luo CQ; Qian LY
    Med Sci Monit; 2014 Nov; 20():2472-7. PubMed ID: 25430553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
    Li BS; Liu H; Yang WL
    Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.